NCT00964249View on ClinicalTrials.gov

Phase I Study of GW642444M in Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

September 20, 2008

Primary Completion Date

December 1, 2008

Study Completion Date

December 1, 2008

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GW642444

Long acting Beta 2 agonist

DRUG

Placebo

Matching placebo

Trial Locations (1)

812-0025

GSK Investigational Site, Fukuoka

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00964249 - Phase I Study of GW642444M in Healthy Japanese Male Subjects | Biotech Hunter | Biotech Hunter